Monday, February 26, 2024

Confidential doc highlights risks of Covid-19 vaccine

A doc from the Pfizer laboratory demonstrates that the modifications made to the vaccine spike protein (substitute of two amino acids at positions 986 and 987) don’t stop it from recognizing and binding to the ECA2 receptor in human cells. This binding of the vaccine spike protein to the ECA2 receptor induces an extra of the hormone angiotensin-2, which overactivates the “deleterious” AT1R receptor on the origin of Covid-19 pathologies. Dr. Jean-Marc Sabatier was the primary to warn of this phenomenon and the potential “deleterious” results related to these vaccines.

Several-billion-people-have-been-vaccinated-against-Covid-UnlemPhotos
A number of-billion-people-have-been-vaccinated-against-Covid-UnlemPhotos

It’s a confidential Pfizer doc (see under web page 9) from 2021. Entitled “Structural and biophysical characterization of the main glycoprotein of SARS-CoV-2 (P2 S) as a vaccine antigen”, this scientific examine is nearly incomprehensible to the layman. It turns into completely intelligible with the reasons of Jean-Marc Sabatier, PhD in cell biology and microbiology, HDR in biochemistry, and Director of Analysis on the CNRS*.

*He’s talking in his personal title.

The spike protein: a string of 1273 pearls

To know this, it’s essential to know that the SARS-CoV-2 spike protein, the one that allows the virus to enter our cells, is a string of amino acid residues similar to a necklace of 1273 pearls (there are globally 20 varieties of pearls – i.e. 20 varieties of amino acid residues – to assemble this necklace).
To develop its Comirnaty vaccine, Pfizer modified two amino acid residues within the spike protein, i.e. two beads, at positions 986 and 987. As a substitute of the amino acids lysine and valine, Pfizer added two prolines (i.e. two equivalent pearls) to create a “pre-fusion” conformation of the spike protein. This explicit form of the spike protein would usually have prevented it from recognizing the ACE2 receptor (angiotensin-2 changing enzyme) on the right track cells.

“A belated admission

Till now, we have been instructed that the vaccine spike protein (a modified type of the spike protein) was unable to acknowledge the ECA2 receptor,” explains Jean-Marc Sabatier. Nonetheless, with this confidential doc, we study that the Pfizer pharmaceutical laboratory knew – in accordance with their very own experimental information – that the vaccine spike protein is able to recognizing the human ACE2 receptor. This additionally explains why vaccines have deleterious results (to not point out the potential deleterious results related to different vaccine elements, together with lipid nanoparticles). Certainly, the anti-Covid-19 vaccine can doubtlessly act just like the virus, with comparable motion of the viral and vaccine spike proteins on the ACE2 receptor, dysregulation of the renin-angiotensin system (RAS) and overactivation of the AT1R receptor.”

Different vaccines affected

Pfizer will not be the one laboratory to have made these modifications to the pearl necklace. The spike proteins of all anti-Covid-19 mRNA vaccines have undergone this modification. And none of those vaccines seem to stop the vaccine spike protein from binding to the ECA2 receptor.
The results are well-known. As with the Sars-CoV-2 virus, the vaccine will decontrol the renin-angiotensin system. “Jean-Marc Sabatier continues: “We have been instructed that this was not attainable as a result of stabilization of a ‘pre-fusion’ conformation for the vaccine spike protein. However Pfizer’s confidential doc reveals that we have been proper. Since 2020 and our first scientific papers, we have now been asserting that the vaccine spike protein, produced specifically by Pfizer’s vaccine, is able to binding to the ACE2 receptor, and that it’s certainly a possible facilitator of Covid-19 pathologies.”

The reality all the time wins out in the long run, regardless of the “consultants” on TV.

Pfizer confidential doc

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles